Clinical Trial

Autologous Hematopoietic Stem Cell Infusion for Prolonged Cytopenia After CAR-T Cell Therapy

Name: Autologous Hematopoietic Stem Cell Infusion for Prolonged Cytopenia After CAR-T Cell Therapy — clinical trial record (NCT07127289)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ICAHT-001

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a prospective, single-arm, single-center clinical study designed to evaluate the safety of autologous hematopoietic stem cell infusion for the treatment of prolonged cytopenia following CAR-T cell therapy. Approximately 20 patients will be enrolled.

Trial Details

NCT Number	NCT07127289
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China
Conditions	Prolonged Cytopenia Following CAR-T Therapy
Enrollment	20 participants
Start Date	2025-08
Primary Completion	2027-08 (estimated)
Study Completion	2028-08 (estimated)
Updated on ClinicalTrials.gov	2025-08-17